overt increase of oxidative stress and dna damage in ......overt increase of oxidative stress and...

Overt Increase of Oxidative Stress and DNA Damage in Murine and Human Colitis and Colitis-associated Neoplasia

Adrian Frick1, †, Vineeta Khare1, †, Gregor Paul1, Michaela Lang1, Franziska Ferk2,

Siegfried Knasmüller2, Andrea Beer3, Georg Oberhuber4 and Christoph Gasche1,*

1 Department of Internal Medicine III, Division of Gastroenterology and Hepatology,

Medical University of Vienna, Währinger Gürtel 18-20, A-1090 Vienna, Austria

2 Institute of Cancer Research, Department of Medicine I, Medical University of

Vienna, Vienna, Austria

3 Clinical Institute of Pathology, Medical University of Vienna, Vienna Austria

4 Pathologie Soleiman, A.ö. Landeskrankenhaus-Universitäts-Kliniken Innsbruck,

Anichstraße 35, 6020 Innsbruck, Austria

† These authors contributed equally to this work.

* Correspondence: Christoph Gasche, M.D., Div. of Gastroenterology and

Hepatology, Medical University of Vienna, Währinger Gürtel 18-20, A-1090 Vienna,

Austria

Phone: +43 40400 47640

Fax: +43 40400 47350

Email: [email protected]

Running Title: Oxidative stress and colon carcinogenesis

Keywords: IL-10, Ulcerative Colitis, Colitis-associated cancer, Oxidative stress, DNA

repair, Double-strand breaks

Financial Support: This study was supported by the Federal Ministry of Economy,

Family and Youth and the National Foundation for Research, Technology and

Development and in part by the Austrian Science Fund (P27681 to CG)

Disclosures: none

Word count: abstract 225, manuscript 4939, references 58; figures 4

on January 23, 2020. © 2018 American Association for Cancer Research.mcr.aacrjournals.org Downloaded from

Author manuscripts have been peer reviewed and accepted for publication but have not yet been edited. Author Manuscript Published OnlineFirst on January 29, 2018; DOI: 10.1158/1541-7786.MCR-17-0451

mailto:[email protected]

http://mcr.aacrjournals.org/

Frick, A. et al. Oxidative stress and colon carcinogenesis

2

Abstract

Patients with inflammatory bowel disease (IBD) have a higher risk of developing

colitis-associated-cancer (CAC), however, the underlying processes of disease

progression are not completely understood. Here, the molecular processes of

inflammation-driven colon carcinogenesis were investigated using IL-10 deficient

mice (IL-10 KO). IL-10 KO mice were euthanized after development of colitis and

dysplasia. Immunohistochemistry (IHC) was performed for markers of colitis-induced

DNA damage (CIDD): oxidative-DNA-lesions (8-oxoG), double-strand breaks (DSB;

γH2AX) and DSB-repair. MSI, LOH (Trp53, Apc) and global methylation (CIMP) were

assessed on microdissected tissue. Comet-assay for DNA damage,

immunofluorescence, and immunoblotting were performed on intestinal organoids

from WT and IL-10 KO mice. Sequential biopsies and surgical specimens from IBD

and CAC patients were used for IHC analysis. Severity of inflammation correlated

with number of dysplasia. 8-oxoG and γH2AX positive cells were significantly

increased in inflamed and dysplastic areas along with activation of DSB repair. The

amount of positively stained cells strongly correlated with degree of inflammation (8-

oxoG: R=0.923; γH2AX: R=0.858). Neither CIMP, MSI nor LOH was observed.

Enhanced DSBs in IL-10 KO organoids were confirmed by comet-assay and

increased expression of γH2AX. Human clinical specimens exhibited significantly

higher γH2AX and 8-oxoG in IBD, dysplasia and CAC compared to normal mucosa.

These data indicate that inflammation-driven colon carcinogenesis in IL-10 KO mice

and IBD patients is associated with oxidative DNA damage and overt presence of

DSB.





3

Introduction

Inflammatory bowel disease (IBD), a chronic inflammation of the gut, is linked to a

high risk of developing colitis-associated cancer (CAC). The molecular mechanisms

involved in colitis-associated carcinogenesis are incompletely understood.

Development of CAC shows mechanistic differences to sporadic colorectal cancer

(CRC) despite shared mechanisms such as chromosomal instability, microsatellite

instability and CpG-island hypermethylation (CIN, MSI and CIMP, respectively).(1) In

contrast to the adenoma-carcinoma sequence of sporadic CRC, CAC lesions are

often multifocal throughout the colonic mucosa and progression is associated with

certain mutations, chromosomal aberrations (such as change in number) and clonal

expansion of those.(2, 3)

Chronic inflammation is considered to drive carcinogenesis by oxidative stress.(4-6)

The upregulated production of reactive oxygen and nitrogen species (ROS and RON,

respectively) cause cellular damage to lipids, proteins and nucleic acids due to an

outrun of scavenging potential. As a consequence, nucleotides can be oxidized (such

as guanine to 8-oxoG) resulting in base transversion (GC-TA), abasic sites and DNA

single- and double-strand breaks.(7-12) For cellular integrity, DNA double-strand

breaks (DSB) can be fatal and their repair is initiated by the cellular DNA damage

response (DDR) consisting of a multi-protein signalling cascade.(13, 14) An early

event in DSB response is phosphorylation of the H2A subtype histone H2AX at ser-

139 (also known as γH2AX) by the phosphatidylinositol 3-like kinases ATM, ATR and

DNA-PK.(15, 16) Phosphorylation of H2AX spreads from the site of a DSB into both

directions, resulting in initiation and maintenance of DDR. Hence, γH2AX is a





4

common marker for DSB formation.(17, 18) Through indirect as well as direct

interactions with proteins like BRCA1 and MRE11 with its BRCT domain, γH2AX

recruits several DDR proteins at DSBs and activates DNA repair either by

homologous recombination (HR) or non-homologous end joining (NHEJ) (19). NHEJ

is a repair process in which the two DNA ends are re-ligated without the need for a

homologue, a pathway that puts DNA integrity above repair fidelity potentially leading

to significant DNA alterations such as mismatches, deletions and even CIN.(20, 21)

In contrast, HR utilizes the sister-chromatid as a template strand to reinstate a correct

DNA sequence.

IL-10 KO mice have been extensively used as a model for IBD and also CAC. These

mice develop spontaneous enterocolitis and concomitant colitis-associated

neoplasia.(22) Interestingly, the mechanism underlying the inflammation-driven

carcinogenesis remains unclear. In a previous study neither MSI or CIN nor k-RAS,

p-53 or APC gene mutations were identified in tumours from IL-10 KO mice.(23) Our

aim was to challenge the molecular pathway of colitis-associated carcinogenesis in

IL-10 KO mice. Here we identified colitis-induced DNA damage (CIDD) and induction

of error-prone NHEJ as drivers of dysplasia in IL-10 KO mice, independent of MSI

and CIMP. Human samples exhibited a similar CIDD with disease progression from

IBD to LGD, HGD and CAC.

Material and Methods

Animal Experiments

C57BL/6 IL-10 KO mice were a kind gift from Dr. Terrence Barrett (University of

Kentucky, Lexington, USA) and bred under specific pathogen free (SPF) conditions.

For experiments, 98 mice were conventionally housed at the Biomedical Research





5

Facility at the Medical University of Vienna. Animals were kept for 27 weeks, a group

of 10 animals was euthanized one week after transfer to non-SPF and used as

inflammation-free control samples. After one week of conventional housing, 43 mice

received piroxicam (Sigma-Aldrich) in their chow (C1000, Altromin, Germany) at a

concentration of 200 ppm for 7 days. Body weight and health status were checked at

least once a week. Animals were euthanized in case of significant weight loss (>20%

within one week) or symptoms of severe inflammation like bloody diarrhoea and

rectal prolapse. Animal studies were performed under the Austrian Animal

Experiments Regulation and approved by the animal experiment committee in

accordance with the institutional good scientific practice guidelines (BMWF-

66.009/0099_II/3b/2011).

Histological Analysis and Inflammation Score

Intestines were dissected, flushed with PBS and coiled up as Swiss rolls followed by

10% formalin treatment as previously described.(24) Haematoxylin and eosin (H&E)

staining was performed on paraffin-embedded sections from mouse intestinal

tissue.(25) Independent histological analysis was carried out by two scientists, one of

which was a pathologist, scoring the number of tumours, the number of high grade

dysplasias (HGD) and the grade of inflammation.(26) Human samples were selected

from endoscopic biopsies or surgical specimens of patients with IBD and CAC.

Written informed consent was obtained from patients. The study was approved by the

local ethics committee (EC number: 1354/2012) and complying with international and

institutional guidelines for good scientific practice.

Immunohistochemistry





6

The human samples were obtained from the Clinical Institute of Pathology at Medical

University of Vienna. Immunohistochemistry of formalin fixed paraffin-embedded

slides was performed as described previously(27) with primary antibodies against 8-

oxoG, γH2AX, MRE11, KU70, BRCA1, Nrf2 and p53 (Supplementary Table 1,

supplementary methods). Briefly, slides were deparaffinised with 2 cycles of xylol and

concomitant rehydration with descendent alcohol series. Heat-induced antigen

retrieval was carried out either with citrate buffer (pH 6) or with Tris EDTA (pH 9) for

nuclear proteins. Normal goat serum buffer was used as blocking solution, followed

by optional M.O.M. (Vector Labs) blocking and subsequent primary antibody

incubation (4°C overnight). Staining was performed using biotinylated antibody,

Avidin-Biotin-HRP-Complex (Vectastain, PK-6100) and diaminobenzidine. Slides

were counterstained with haematoxylin (Merck 5174).

Laser Capture Microdissection

Tissue sections mounted on PEN (polyethylene naphthalate) slides (Leica

Microsystems®, Wetzlar, Germany) were dissected using the LMD6000 laser

microdissection microscope (Leica Microsystems®) to obtain samples from non-

inflamed, inflamed and dysplastic intestinal epithelium. DNA was extracted from the

microdissected samples using the QIAamp DNA FFPE tissue kit (Qiagen, Venlo,

Netherlands) according to the manufacturer’s instructions.

Loss of Heterozygosity (LOH) and MSI-Analysis

LOH was examined for Trp53 (chromosome 11; 42,8cM) and Apc (chromosome 18;

18,5cM) with 3 loci-aligning dinucleotide PCR amplifications, which were selected

from the ABI prism mouse mapping primer list (supplementary methods). For Trp53





7

the primer pairs were specific for segments D11mit86 (25.1cM), D11mit4 (36.1cM)

and D11mit285 (49.2cM). Apc markers were specific for segments D18mit12 (9.8cM),

D18mit177 (14.2cM) and D18mit91 (19.7cM). For amplification the Multiplex PCR Kit

(Qiagen®, Venlo, Netherlands) was used. All primers were labelled with fluorescent

dye (FAM, NED, VIC, supplementary table 2). The PCR reaction consisted of 7.5 µL

master mix, 1.5 µL Solution Q, 0.5 µL per primer (6 primers per reaction) and a DNA

amount of 5-10 ng. For MSI analysis reagents were combined prior to analysis:

8.6 µL formamide, 0.4 µL GeneScan 500 LIZ size standard (Applied Biosystems) and

0.4 µL PCR product followed by a denaturation step at 95°C and immediately cooled

on ice. Carried out under following PCR conditions: 15 min at 95°C, 35 cycles at

94°C for 30 s; 60°C for 30 s and 72°C for 30 s; followed by 72°C for 10 min. Analysis

was done by comparing non-inflamed, inflamed and dysplastic tissue using

GeneMapper Software 4.0. To additionally analyse the microsatellite status 4

dinucleotide and 2 polyA repeat markers were used (supplementary table 3) and

handled and analysed as previously described.(28) All experiments were carried out

on a Genetic Analyzer 3500 (Applied Biosystems).

Methylation Analysis

To determine the global DNA methylation status, DNA from microdissected tissue

was converted using EpiMark® Bisulfite Conversion Kit (New England Biolabs)

according to the manufacturer’s protocol (supplementary methods).

TUNEL Staining

To assess the number of apoptotic cells in mouse tissue samples TUNEL staining

(TdT-mediated dUTP-biotin nick end labelling) was performed according to





8

manufacturer’s protocol, using the In Situ Cell Death Detection kit (Roche®). See

supplementary methods.

Isolation of Small Intestinal Organoids and Western Blotting

Small intestinal and large bowel organoids (SIOs, LBOs, respectively) were prepared

from IL-10 KO and wild type (WT) mice.(29) Organoids were cultured in matrigel with

a passage every 3-5 days in a 1:2 ratio. Treatment of organoids was carried out with

TNFα (10 ng/mL, eBioscience BMS301), IL-6 (10 ng/mL, eBioscience BMS341),

recombinant murine IL-10 (rmIL-10, 10 ng/mL, Preprotech, 210-10), rmIL-22

(10ng/mL, eBioscience 14-8221-63) and sulforaphane (10µM, Sigma Aldrich S4441)

for 24 h or with H2O2 (100 µM) for 1 h. For Western blotting organoids were washed

and re-suspended in 1 mL PBS and transferred into a precooled Eppendorf tube

followed by centrifugation at 400 g for 5 min at 4 °C. Supernatant was discarded and

the washing step repeated. The cell pellet was lysed in RIPA buffer (on ice for 10

min) followed by a short sonication and subsequent cooling on ice for 30 min. Using

Bradford assay, protein concentration was measured and 20 µg of protein was used

for SDS-PAGE. Immunoblotting was performed on a PVDF membrane. The protein

bands were visualized with IRDye coupled anti-rabbit or anti-mouse antibodies (either

or both mouse/rabbit; LI-COR) and scanned on Odyssey imager (LI-COR

Biotechnology).

Immunofluorescence Microscopy

For immunofluorescence (IF) SIOs and LBOs were fixed in 4% paraformaldehyde at

room temperature for 30 min and blocked in horse serum with 0.1% Triton X-100 for

1h. Samples were incubated with primary antibody in 1% BSA/PBS overnight at 4°C,

then washed and incubated with secondary antibody (Alexa Fluor® 488) for 1 h at





9

room temperature. Then samples were washed, dried and mounted with DAPI

containing medium (Vector Laboratories), and imaged on an Olympus BX51

microscope. Evaluation of γH2AX staining was carried out using ImageJ

(supplementary methods)

Alkaline Single Cell Gel Electrophoresis Assay (Comet-Assay)

The experiments were carried out according to the international guidelines.(30) To

detect formation of oxidative stress, additional experiments with a lesion-specific

enzyme (formamidopyrimidine DNA glycosylase; FPG) were conducted as described

(supplementary methods).(31)

Statistics

Means of normal distributed data were compared using unpaired Student’s t-test;

non-parametric Mann-Whitney U test was used not normally distributed data. Tumour

incidence and inflammation analysis were tested with Pearson’s Chi Square test.

Correlation between grade of inflammation and expression of certain markers was

assessed by Spearman’s rank correlation. Two-sided analysis of variance (ANOVA)

with Dunnet post-hoc analysis was used to compare all subgroups together. If p-

values were equal or less 0.05 they were considered as statistically significant

(*p≤0.05; **p<0.01; ***p<0.001). GraphPad Prism 6.01 software (GraphPad Software,

La Jolla California, USA) was used to analyse all data.

Results

Inflammation and Tumour Incidence in IL-10 KO Mice

IL-10 KO mice were used as model to investigate the mechanism underlying

inflammation-driven carcinogenesis. To induce a high degree of inflammation and





10

synchronize inflammation onset (and secondary tumorigenesis), half of the mice were

treated with piroxicam for 1 week.(26, 32) Distal inflammation and dysplasia were

assessed by colonoscopy after 5 month, at which point piroxicam fed animals

exhibited more signs of inflammation and higher number of dysplastic or hyperplastic

lesions compared to untreated IL-10 KO mice (Figure 1A). Animals were euthanized

after 27 weeks and intestines were prepared for further analysis. Histological

inflammation scoring revealed an average inflammation grade of 2.86±0.63

(95%CI=2.66-3.06) with a prevalence of 100% for the piroxicam fed mice (n=43), and

1.8±0.81 (95%CI=1.55-2.04) with a prevalence of 84.1% for the group without

piroxicam (n=45, p<0.001). Tumour counting showed a total number of 13 high-grade

dysplastic lesions (HGD) and 4 invasive carcinomas were found in untreated IL-10

KO. Piroxicam fed IL-10 KO mice had 25 HGD (p<0.05) and 6 invasive carcinomas

(Figure 1B, Supplementary figure 1A, Supplementary Table 4). The severity of

inflammation correlated to the number of dysplastic lesions (R=0.728, p<0.01; Figure

1C) in piroxicam-treated mice. Due to the low number of affected mice in the

untreated group, all following experiments were carried out with samples from

piroxicam-treated mice only.

Absence of MSI, LOH and CIMP in IL-10 KO Mice

To examine the molecular pathways leading to colorectal carcinogenesis in IL-KO

mice, we analysed MSI, LOH and CIMP in DNA from microdissected samples (non-

inflamed, inflamed and dysplastic). Fragment analysis was performed for MSI and

LOH analysis using certain markers. Three markers, each aligning the Trp53 or Apc

gene, were investigated for LOH, whereas 6 markers were additionally utilized for

MSI analysis.(25) Of all analysed dysplastic samples, LOH could not be detected at

any marker when comparing dysplastic or inflamed tissue to non-inflamed mucosa





11

samples. No peak loss was observed and calculated peak-ratios revealed no change.

Fragment analysis also revealed no change at any of the six microsatellites in any of

the dysplastic or inflamed samples compared to non-inflamed tissue

(Supplementary figure 2A, B). These data indicate that neither LOH at Trp53 or

Apc nor MSI is involved in colorectal tumour development in this CAC model.

To assess the CIMP, the murine B1 element was analysed using primers specific for

the methylated or unmethylated sequence. Tumour-DNA from dysplasia bearing mice

was bisulfite converted and compared to converted non-inflamed tissue samples as

control. Quantification of the target sequences revealed no significant change in the

levels of methylated or unmethylated CIMPs(Supplementary figure 2C), indicating

that global methylation was not affected as well.

CIDD Increases with Mucosal Inflammation and Neoplastic Transformation

Resulting in DSBs and Associated DDR

As the common molecular pathways of sporadic colorectal carcinogenesis were not

affected we further tested for the presence of oxidative stress and DNA damage

response. The formation of DNA lesions, such as 8-oxoG, due to generation of ROS

and NOS, is considered as a marker of oxidative stress. We examined dysplastic,

inflamed and non-inflamed samples for 8-oxoG lesions and assessed the ratio of

positive stained cells/per crypt at 400x magnification (Figure 2, left panel). A

significant correlation was detected between the inflammation grade and the

presence of 8-oxoG positive cells (R=0.923; p<0.01), indicative for a mucosal

increase in oxidative DNA damage with the degree of intestinal inflammation. This

effect was also observed with disease progression as there was a significant

increase in 8-oxoG positive cells in dysplastic tissue (Figure 2, right panel).





12

Oxidation of DNA bases can lead to single- and DSBs due to creation of abasic or

complex DNA damage sites by several 8-oxoGs in close proximity.(7, 33) To assess

the level of DSBs in colitis and dysplasia we stained for phosphorylated histone

H2AX, yH2AX, an early event in DSB response. Dysplastic, inflamed and non-

inflamed samples were evaluated according to the ratio of positive nuclei per crypt at

400x magnification. The amount of positively stained nuclei was significantly

increased in inflamed (p<0.001) and dysplastic tissue (p<0.001) compared to non-

inflamed tissue. The increased staining was predominant in basal crypt region and in

the intermediate zone (Figure 2, left panel). Additionally, the increase in DSBs

positively correlated to the degree of inflammation (R=0.858, p<0.001). (Figure 2,

right panel)

If not repaired, DSBs are hazardous for cell survival. In fact, phosphorylation of H2AX

initiates DNA damage response and DSB repair. To assess the exact DDR

mechanism, samples were stained for MRE11, representing the MRN-complex

(MRE11-RAD50-NBS1) that induces the DSB response. Furthermore, it interacts with

DSB repair proteins such as KU70 (which together with KU80 binds to DSB ends and

is required for NHEJ and BRCA1 (involved in HR), which were further analysed.

Dysplastic samples were stained and compared to inflamed and non-inflamed

samples. An increase of positive stained nuclei in inflamed (p<0.01) and dysplastic

tissue compared to non-inflamed for each MRE11, BRCA1 and KU70 (p<0.001) was

observed indicating an upregulation of DDR for both NHEJ and HR (Figure 2, left

panel). Also, a positive correlation existed between grade of inflammation and rate of

positive nuclei (MRE11: R=0.785, p<0.01; BRCA1: R=0.921, p<0.01, KU70:

R=0.851, p<0.01; Figure 2, right panel). This data support the notion that in contrast

to MSI or CIN, DSBs are the major oxidative DNA lesion within the mucosal





13

proliferative zone with induction of both HR and NHEJ which likely affects DNA

fidelity in intestinal stem cells.

As a consequence of DSBs, damaged cells can either survive (after DNA repair) or

undergo apoptosis. To test whether the lesions are associated with apoptosis,

TUNEL-staining was performed. We did not detect an increase in apoptotic cells in

inflamed and dysplastic crypts (Supplementary figure 3) indicating that the DSBs

did not trigger apoptosis.

Intestinal IL-10 KO Organoids Exhibit Increased DSBs

To validate the in vivo findings observed in IL-10 KO mice, an ex vivo model of

intestinal organoids from WT and IL-10 KO mice was used. To examine whether

DNA damage could be induced in organoids they were treated with either pro-

inflammatory cytokines TNF-α and IL-6 (for 24h) or with oxidative stress inducer

hydrogen peroxide (H2O2, for 1h). γH2AX was increased upon treatment with TNF-α,

IL-6 or H2O2. When compared to WT, phosphorylated H2AX was higher in untreated

IL-10 KO organoids corroborating the observations in IL-10 KO mice (Figure 3A). An

increase in spontaneous DSBs upon IL-10 deficiency was further confirmed by comet

assay and modified FPG- comet assay (which detects oxidative DNA damage by

strand break induction at oxidized DNA bases) of these SIOs (Figure 3B).

Immunofluorescence confirmed higher basal levels of nuclear γH2AX in IL-10 KO

organoids (Figure 3C) again implying ongoing DSBs in IL-10 KO organoids

compared to WT. Treatment with H2O2 further increased DSBs, while IL-10 treatment

reverted the amount of DSBs in IL-10 KO organoids compared to untreated,

presumably due to a reduction in cellular levels of ROS. IL-22 treatment showed no

effect on γH2AX (Figure 3C, D). One of the main cellular sensors of oxidative stress

is Nrf2, which coordinates the expression of antioxidant proteins.(34, 35) In fact,





14

aberrant cytoplasmic accumulation of Nrf2 was observed in IL-10 KO organoids

compared to WT (Supplementary figure 4A). Activating Nrf2 using sulforaphane

(SF) did not change the amount of γH2AX found in LBOs (supplementary figure

4B). We further investigated the level of STAT3 phosphorylation after treatment with

SF, IL-10 or IL-22. Activation of Nrf2 with SF showed no profound effect on STAT3

phosphorylation between WT and IL-10 KO LBOs. IL-22 treatment resulted in the

strongest STAT3 phosphorylation in both WT and IL-10 KO organoids

(supplementary figure 4C). These data suggest increased basal levels of DSBs in

IL-10 KO organoids, likely due to an excessive presence of ROS and reduced

scavenging potential indicated by cytoplasmic accumulation of Nrf2, a condition

which can be attenuated by IL-10 treatment.

γH2AX as Marker of CIDD in Human IBD

To evaluate the presence of CIDD in IBD and CAC we also examined γH2AX in

colonic tissue sections from biopsies and surgical specimens of patients with normal

mucosa, IBD, low-grade dysplasia (LGD), HGD, CAC, CAC-adjacent tissue, CRC

and familial adenomatous polyposis samples (FAP) (Figure 4A). 8-oxoG staining

was used to evaluate levels of oxidative stress in normal, IBD and CAC samples. Of

all 52 analysed samples, sequential specimen from six patients were available

(Figure 4B, upper panel and coloured bars). They all exhibited a sequential

increase in γH2AX from LGD or HGD to CAC. Biopsies identified as LGD already

show distinct γH2AX positive areas, with a threshold above 20% positive cells. This is

also true for IBD surveillance biopsies of patients, who later developed a LGD or

HGD. The CAC-adjacent tissue exhibited specific crypts, solely positive for γH2AX,

potentially marking crypts indefinite for dysplasia. (Figure 4A). The highest level of

γH2AX was observed in LGD, HGD and CAC samples (p<0.001) as well as in CRC





15

(p<0.01) (Figure 4C). Interestingly, the staining for p53 revealed a similar pattern as

seen in HGD and CAC-γH2AX staining with nuclear accumulation of p53 (Figure

4B/D). Quantifying the marker for oxidative stress revealed already overt presence of

8-oxoG in IBD samples, with almost 70% positive nuclei (p<0.001) and also in CAC

(p<0.001) (Figure 4E). These findings show overt CIDD, marked by 8-oxoG and

γH2AX, and its involvement in the sequence from IBD to LGD to HGD to CAC.

Discussion

Patients with ulcerative colitis are at risk for developing colorectal cancer. The

molecular events of inflammation-driven carcinogenesis are incompletely understood

and differ from sporadic colorectal cancer as well as familial cancer syndromes.

Although oxidative DNA damage is considered the driving force of mutagenesis in

this setting, the actual molecular DNA lesion and the associated DNA repair pathway

have not been investigated. Here we studied these molecular events in IL-10-

deficient mice, a well-established model of CAC. We confirm that MSI, LOH and

CIMP were not observed in these mice (23). Instead oxidative DNA lesions (i.e. 8-

oxoG) were found in the crypts of IL-10 KO mice and were associated with

upregulation of DSB response and repair proteins (like γH2AX, MRE11, BRCA1 and

KU70). Ex-vivo, IL-10 KO organoids displayed spontaneous DSBs. Human sections

also exhibited an increase in 8-oxoG in IBD and CAC. γH2AX was induced in LGD,

HGD, tumour adjacent and CAC tissue. Therefore we believe that DSBs as the core

molecular lesion in CIDD and inflammation-driven carcinogenesis. Activation of the

DSB-repair pathway promotes cell survival and potential accumulation of mutations

leading to CAC.





16

Both, RONs and ROS contribute to DNA damage.(6, 36, 37) In fact, 8-oxoG

increased with the grade of inflammation and was present in dysplastic lesions of IL-

10 KO mice.(38, 39) Similar γH2AX and DSB repair proteins increased with the grade

of inflammation and dysplasia without inducing apoptosis. Induction of DSBs were

previously reported for UC, gastric cancer and in ATM-deficient mice upon dextran

sodium sulphate.(40-43) Compared to HR, NHEJ is considered error prone because

of the direct ligation of broken DNA ends without a homologous template. NHEJ is

active in all cell cycle states and appears to be more effective than HR, yet results in

more DNA deletions and translocations.(44) Our data suggests that besides HR also

NHEJ is active and a possible mutational driver in this setting. In the absence of

alteration in other examined molecular mechanisms (MSI, LOH, CIMP), this seems to

be a predominant pathway of carcinogenesis in IL-10 KO mice. Abundance of CIDD

together with error prone repair might predispose to accumulation and expansion of

pre-mutagenic lesion. Additionally, crypt cells under inflammatory stress have higher

proliferation rates and are therefore under constant replication stress, which is

another cause of increased DSBs.(8, 45)

In the ex-vivo model, IL-10-deficient organoids displayed spontaneous DSBs without

the presence of inflammatory cells or cytokines, a condition which could be reverted

by addition of recombinant IL-10. In parallel, Nrf2 was found mainly in its aberrant

cytoplasmic location. As Nrf2 elicits its ROS scavenging function as a transcription

factor, cytoplasmic accumulation indicates an impaired activity, thereby showing a

diminished potential to reduce ROS in IL-10 KO organoids. Remarkably, Nrf2 was

shown to facilitate HR and its activation protects from DNA. On the contrary,

inhibition of Nrf2 activity led to increase in γH2AX and reduced DSB-repair.(46, 47)

Using sulforaphane as an Nrf2 activator we could not detect a change in DSB levels





17

in IL-10 KO organoids. Such an effect has been postulated for skin after UV radiation

or in human lymphocytes after contact with DNA damaging substances. (48, 49) The

abrogated Nrf2 signalling in IL-10 KO mice possibly enhances intracellular ROS,

DNA damage and NHEJ. The overt presence of ROS is likely further sustained as

foci of γH2AX were shown to trigger and maintain pro-inflammatory cytokine

secretion.(50) . Our experiments showed no overt phosphorylation of STAT3 or a

difference in its phosphorylation levels between WT- and IL-10 KO organoids, after

Nrf2 activation or cytokine treatment. The effect of IL-10 itself might be attributable to

its ability to regulate oxidative homeostasis. (51) Nevertheless, further research is

needed to elucidate potential interaction and crosstalk between Nrf2 and the IL-10-

STAT3 signalling cascade. IL-10 itself is known to regulate oxidative

homeostasis.(51)

Our mouse and ex-vivo findings were verified in human tissue section. The

longitudinal analysis of IBD samples revealed a similar pattern of CIDD as observed

in IL-10 KO mice. An increase in DSBs was seen in LGD, HGD and CAC samples

compared to normal biopsies. Samples from IBD patients showed at least 20%

γH2AX positive nuclei (per crypt), if they developed LGD in later stages. We also

examined p53 expression, considered as one of the first-hit targets in the sequela of

IBD to CAC and having a critical role in DDR.(52, 53) The areas with nuclei positive

for p53 were mostly seen in HGD and CAC samples and were associated with

γH2AX positive areas. Although a normal p53 function cannot be ruled out, given the

fact that these are already progressed neoplasias, it is likely that the observed

nuclear accumulation of p53 indicates a non-functional mutated protein.(54, 55)

Hence, this creates a condition of cellular damage and survival resulting in

carcinogenesis.





18

Here, we propose γH2AX as a marker for CIDD and disease progression for

surveillance endoscopy in IBD. Evaluating H2AX activation was already tested in

various malignancies such as gastric, lung- and cervical cancer and it is discussed as

a potential marker for cancer progression as well as for radiation- and chemotherapy

response.(45, 56-58) In IBD, the risk of developing CAC is heterogeneous and

relates to duration, extent and severity of disease. γH2AX-staining of biopsies from

surveillance endoscopy may help separating those individuals at risk from those

without. More studies are needed before we can use this biomarker for adjusting

surveillance intervals or selecting patients who benefit most from chemoprevention or

surgery.

Acknowledgement

This study was supported by the Federal Ministry of Economy, Family and Youth and

the National Foundation for Research, Technology and Development and in part by

the Austrian Science Fund (P27681 to CG)

IL-10 KO mice were gratefully provided by Dr. Terrence A. Barrett and Jeffrey B.

Brown, Northwestern University, Feinberg School of Medicine, Chicago, Illinois.

Author contributions: Study concept and design: VK, AF, GP, CG. Drafting of

manuscript: AF, VK. Data acquisition and interpretation: AF, VK, GP, ML, FF, GO.

Critical revision of the manuscript: VK, CG. Statistical analysis: AF, ML. Obtained

funding: CG. Technical or material support: SK, AB.





19

FIGURE LEGENDS

Figure 1: Inflammation and disease progression in IL-10 KO mice.

A: Results of colonoscopy indicating percentage of dysplastic and inflamed lesions in

investigated mice (IL-10 KO: n=20, IL-10 KO piroxicam n=9). Exemplary colonoscopy

pictures showing non-inflamed, inflamed and dysplastic areas of the murine large

bowel B: Percentage of mice with histologically determined high-grade dysplastic

lesions and invasive carcinomas. C: Piroxicam fed mice exhibit higher grades of

inflammation (t-test, two-tailed, ***p<0.001) compared to IL-10 KO mice fed with

normal chow. The number of dysplastic lesions was positively correlated to the grade

of inflammation (Spearman-Rho, R= 0.701 for control and R=0.728 for piroxicam-

group, **p<0.01).

Figure 2: Oxidative stress is upregulated with grade of inflammation and

disease progression in IL-10 KO, resulting in increased DSBs and upregulated

DDR

Left panel with staining for γH2AX (showing DSBs), 8-oxoG (oxidative stress),

MRE11 (DDR), BRCA1 (representative for HR) and KU70 (representative for NHEJ)

on non-inflamed, inflamed and dysplastic samples. Right panel with inflammation

grading (grade 0-4) and disease progression. γH2AX positive nuclei are significantly

increased in inflamed (***p<0.001) and dysplastic samples (*** p<0.001), indicating

increase in DSBs with disease severity, predominantly in the basal crypt region and

the intermediate zone. Disease progression shows increase of DSBs from non-

inflamed to inflamed to dysplastic tissue. The number of DSBs significantly correlates

with the grade of inflammation (R= 0.858, p<0.001). An increase in 8-oxoG positive

cells is seen with increase in disease severity. Disease progression from non-





20

inflamed to inflamed to dysplastic tissue shows a significant increase in oxidative

DNA damage (***p<0.001). A significant positive correlation is seen between grade of

inflammation and 8-oxoG positive cells; (R=0.923, p<0.01). An increase of DDR and

DNA repair mechanism is detected in the crypts of inflamed and in dysplastic

samples. IRS of DDR and DNA repair proteins indicate significant increase with

disease severity (**p<0.01; ***p<0.001) and strong positive correlation with grade of

inflammation (MRE11: R=0.785, p<0.01; BRCA1: R=0.921, p<0.01, KU70: R=0.851,

p<0.01). Statistical analysis was done with ANOVA using Dunnet post hoc analysis

and Spearman Rho for correlation analysis. DDR: DNA damage response, HR:

homologous recombination, IHC: immunohistochemistry, IRS: immunoreactivity

score, NHEJ: non-homologous end-joining

Figure 3: Increased DSBs in IL-10 KO intestinal organoids

A.Western blot analysis of proteins from small intestinal- and large bowel organoids

(WT, IL-10 KO) treated with pro-inflammatory cytokines TNF-α, IL-6 (24 h) and H2O2

(1 h) showed increase of γH2AX after pro-inflammatory treatment, profoundly in IL-10

KO organoids. Actin and tubulin were used as loading control. B: DSBs in WT and IL-

10 KO organoids were analysed using comet-assay, with and without FPG. FPG

treatment induces further breaks at oxidized DNA bases, thereby detecting oxidative

DNA damage, (t-test, two-tailed, ***p<0.001). IL-10 KO organoids exhibited more

DSBs and oxidative DNA damage than WT organoids, in classic comet assay and

FPG-comet assay, respectively. C: IF with antibody against γH2AX (green) and DAPI

to visualize nuclei in WT and IL-10 KO organoids. DSBs are increased in IL-10 KO

organoids, while treatment with 10 ng/mL rmIL-10 reduced the amount of positive

γH2AX foci in IL-10 KO organoids compared to untreated IL-10 KO SIOs. D: Western

blot of LBOs treated with either rmIL-10 or rmIL-22, showing a reduction in γH2AX





21

after rmIL-10 treatment. FPG: Formamidopyrimidine glycosylase, IF:

Immunofluorescence, LBO: large bowel organoid, SIO: small intestinal organoid

Figure 4: γH2AX as a marker of CIDD in patients with IBD.

A: Exemplary pictures of γH2AX staining of human samples (normal, IBD, LGD,

HGD, tumour adjacent, CAC, CRC, FAP) indicating increase of DSBs with disease

progression and severity. B: Analysis of patient samples stained for γH2AX, each bar

represents a patient, coloured bars indicate the same patient with available

sequential biopsy and surgical samples. Profound increase of γH2AX positive nuclei

marking DSBs is seen in LGD, HGD and CAC samples. Below the x-axis

corresponding p53 staining (D) is shown as either – (nuclei p53 negative) or + (nuclei

p53 positive) C: Cumulative analysis of γH2AX staining showing significantly higher

levels for CAC, HGD, LGD (***p<0.001) and CRC (**p<0.01) samples compared to

normal mucosa. E: IHC for 8-oxoG in human colon samples from healthy subjects,

IBD- and CAC-patients, showing overt presence of oxidized DNA damage in IBD and

CAC samples. IRS of 8-oxoG levels are significantly increased in IBD (***p<0.001)

and CAC (***p<0.001). Statistical analysis was done with two-sided ANOVA using

Dunnet post hoc analysis. CAC: colitis-associated cancer, HGD: high-grade

dysplasia, IBD: inflammatory bowel disease, IHC: Immunohistochemistry, IRS:

Immunoreactivity score, LGD: low-grade dysplasia





22

References

1. Ullman Ta, Itzkowitz SH. Intestinal inflammation and cancer. Gastroenterology. 2011;140:1807-16. 2. Rabinovitch PS, Dziadon S, Brentnall TA, Emond MJ, Crispin DA, Haggitt RC, et al. Pancolonic chromosomal instability precedes dysplasia and cancer in ulcerative colitis. Cancer Res. 1999;59:5148-53. 3. Shivakumar BM, Chakrabarty S, Rotti H, Seenappa V, Rao L, Geetha V, et al. Comparative analysis of copy number variations in ulcerative colitis associated and sporadic colorectal neoplasia. Bmc Cancer. 2016;16:271. 4. Wiseman H, Halliwell B. Damage to DNA by reactive oxygen and nitrogen species: role in inflammatory disease and progression to cancer. The Biochemical journal. 1996;313 ( Pt 1):17-29. 5. Phillips LL. Effect of Free Radicals on Chromosomes of Barley. Science. 1956;124:889-90. 6. Hussain SP, Hofseth LJ, Harris CC. Radical causes of cancer. Nature reviews Cancer. 2003;3:276-85. 7. Limoli CL, Giedzinski E. Induction of chromosomal instability by chronic oxidative stress. Neoplasia. 2003;5:339-46. 8. Kiraly O, Gong G, Olipitz W, Muthupalani S, Engelward BP. Inflammation-induced cell proliferation potentiates DNA damage-induced mutations in vivo. PLoS genetics. 2015;11:e1004901. 9. Ohnishi S, Ma N, Thanan R, Pinlaor S, Hammam O, Murata M, et al. DNA damage in inflammation-related carcinogenesis and cancer stem cells. Oxidative medicine and cellular longevity. 2013;2013:387014. 10. Yermilov V, Rubio J, Ohshima H. Formation of 8-nitroguanine in DNA treated with peroxynitrite in vitro and its rapid removal from DNA by depurination. FEBS Lett. 1995;376:207-10. 11. Harrison L, Brame KL, Geltz LE, Landry AM. Closely opposed apurinic/apyrimidinic sites are converted to double strand breaks in Escherichia coli even in the absence of exonuclease III, endonuclease IV, nucleotide excision repair and AP lyase cleavage. DNA Repair (Amst). 2006;5:324-35. 12. Hegde ML, Izumi T, Mitra S. Oxidized base damage and single-strand break repair in mammalian genomes: role of disordered regions and posttranslational modifications in early enzymes. Progress in molecular biology and translational science. 2012;110:123-53. 13. O'Connor L, Harris AW, Strasser A. CD95 (Fas/APO-1) and p53 signal apoptosis independently in diverse cell types. Cancer research. 2000;60:1217-20. 14. Jackson SP, Bartek J. The DNA-damage response in human biology and disease. Nature. 2009;461:1071-8. 15. Firsanov DV, Solovjeva LV, Svetlova MP. H2AX phosphorylation at the sites of DNA double-strand breaks in cultivated mammalian cells and tissues. Clinical epigenetics. 2011;2:283-97. 16. Podhorecka M, Skladanowski A, Bozko P. H2AX Phosphorylation: Its Role in DNA Damage Response and Cancer Therapy. J Nucleic Acids. 2010;2010. 17. Rogakou EP, Pilch DR, Orr aH, Ivanova VS, Bonner WM. DNA Double-stranded Breaks Induce Histone H2AX Phosphorylation on Serine 139. Journal of Biological Chemistry. 1998;273:5858-68. 18. Bassing CH, Alt FW. H2AX may function as an anchor to hold broken chromosomal DNA ends in close proximity. Cell cycle (Georgetown, Tex). 2004;3:149-53. 19. Chapman JR, Taylor MR, Boulton SJ. Playing the end game: DNA double-strand break repair pathway choice. Mol Cell. 2012;47:497-510. 20. Kuhfittig-Kulle S, Feldmann E, Odersky A, Kuliczkowska A, Goedecke W, Eggert A, et al. The mutagenic potential of non-homologous end joining in the absence of the NHEJ core factors Ku70/80, DNA-PKcs and XRCC4-LigIV. Mutagenesis. 2007;22:217-33. 21. Guirouilh-Barbat J, Huck S, Lopez BS. S-phase progression stimulates both the mutagenic KU-independent pathway and mutagenic processing of KU-dependent intermediates, for nonhomologous end joining. Oncogene. 2008;27:1726-36. 22. Kühn R, Löhler J, Rennick D, Rajewsky K, Müller W. Interleukin-10-deficient mice develop chronic enterocolitis. Cell. 1993;75:263-74. 23. Sturlan S, Oberhuber G, Beinhauer BG, Tichy B, Kappel S, Wang J, et al. Interleukin-10-deficient mice and inflammatory bowel disease associated cancer development. Carcinogenesis. 2001;22:665-71. 24. Dammann K, Khare V, Harpain F, Lang M, Kurtovic A, Mesteri I, et al. PAK1 Promotes Intestinal Tumor Initiation. Cancer prevention research. 2015;8:1093-101. 25. Kortum B, Campregher C, Lang M, Khare V, Pinter M, Evstatiev R, et al. Mesalazine and thymoquinone attenuate intestinal tumour development in Msh2loxP/loxP Villin-Cre mice. Gut. 2014.





23

26. Berg DJ, Zhang J, Weinstock JV, Ismail HF, Earle KA, Alila H, et al. Rapid development of colitis in NSAID-treated IL-10-deficient mice. Gastroenterology. 2002;123:1527-42. 27. Khare V, Paul G, Movadat O, Frick A, Jambrich M, Krnjic A, et al. IL10R2 Overexpression Promotes IL22/STAT3 Signaling in Colorectal Carcinogenesis. Cancer immunology research. 2015. 28. Gray SE, Kay EW, Leader M, Mabruk M. Analysis of APC allelic imbalance/loss of heterozygosity and APC protein expression in cutaneous squamous cell carcinomas. Cancer genomics & proteomics. 2011;8:149-55. 29. Dammann K, Khare V, Lang M, Claudel T, Harpain F, Granofszky N, et al. PAK1 modulates a PPAR gamma/NF-kappa B cascade in intestinal inflammation. Bba-Mol Cell Res. 2015;1853:2349-60. 30. Burlinson B, Tice RR, Speit G, Agurell E, Brendler-Schwaab SY, Collins AR, et al. Fourth International Workgroup on Genotoxicity testing: results of the in vivo Comet assay workgroup. Mutat Res. 2007;627:31-5. 31. Campregher C, Schmid G, Ferk F, Knasmuller S, Khare V, Kortum B, et al. MSH3-Deficiency Initiates EMAST without Oncogenic Transformation of Human Colon Epithelial Cells. Plos One. 2012;7. 32. Holgersen K, Kvist PH, Markholst H, Hansen AK, Holm TL. Characterisation of enterocolitis in the piroxicam-accelerated interleukin-10 knock out mouse - A model mimicking inflammatory bowel disease. Journal of Crohn's & colitis. 2013. 33. Ames BN, Shigenaga MK, Gold LS. DNA lesions, inducible DNA repair, and cell division: three key factors in mutagenesis and carcinogenesis. Environmental health perspectives. 1993;101 Suppl 5:35-44. 34. Kobayashi M, Yamamoto M. Nrf2-Keap1 regulation of cellular defense mechanisms against electrophiles and reactive oxygen species. Advances in enzyme regulation. 2006;46:113-40. 35. Lin PL, Chang JT, Wu DW, Huang CC, Lee H. Cytoplasmic localization of Nrf2 promotes colorectal cancer with more aggressive tumors via upregulation of PSMD4. Free radical biology & medicine. 2016;95:121-32. 36. Kawanishi S, Hiraku Y. Oxidative and nitrative DNA damage as biomarker for carcinogenesis with special reference to inflammation. Antioxidants & redox signaling. 2006;8:1047-58. 37. Singer II, Kawka DW, Scott S, Weidner JR, Mumford Ra, Riehl TE, et al. Expression of inducible nitric oxide synthase and nitrotyrosine in colonic epithelium in inflammatory bowel disease. Gastroenterology. 1996;111:871-85. 38. Roessner A, Kuester D, Malfertheiner P, Schneider-Stock R. Oxidative stress in ulcerative colitis-associated carcinogenesis. Pathology, research and practice. 2008;204:511-24. 39. D'Inca R, Cardin R, Benazzato L, Angriman I, Martines D, Sturniolo GC. Oxidative DNA damage in the mucosa of ulcerative colitis increases with disease duration and dysplasia. Inflamm Bowel Dis. 2004;10:23-7. 40. Westbrook AM, Schiestl RH. Atm-deficient mice exhibit increased sensitivity to dextran sulfate sodium-induced colitis characterized by elevated DNA damage and persistent immune activation. Cancer research. 2010;70:1875-84. 41. Lin R, Xiao D, Guo Y, Tian D, Yun H, Chen D, et al. Chronic inflammation-related DNA damage response: a driving force of gastric cardia carcinogenesis. Oncotarget. 2015;6:2856-64. 42. Risques RA, Lai LA, Brentnall TA, Li L, Feng Z, Gallaher J, et al. Ulcerative colitis is a disease of accelerated colon aging: evidence from telomere attrition and DNA damage. Gastroenterology. 2008;135:410-8. 43. Lessel W, Silver A, Jechorek D, Guenther T, Roehl FW, Kalinski T, et al. Inactivation of JNK2 as carcinogenic factor in colitis-associated and sporadic colorectal carcinogenesis. Carcinogenesis. 2017. 44. Guirouilh-Barbat J, Huck S, Bertrand P, Pirzio L, Desmaze C, Sabatier L, et al. Impact of the KU80 pathway on NHEJ-induced genome rearrangements in mammalian cells. Molecular cell. 2004;14:611-23. 45. Gorgoulis VG, Vassiliou L-vF, Karakaidos P, Zacharatos P, Kotsinas A, Liloglou T, et al. Activation of the DNA damage checkpoint and genomic instability in human precancerous lesions. 2005:907-13. 46. Jayakumar S, Pal D, Sandur SK. Nrf2 facilitates repair of radiation induced DNA damage through homologous recombination repair pathway in a ROS independent manner in cancer cells. Mutation research. 2015;779:33-45. 47. Kim SB, Pandita RK, Eskiocak U, Ly P, Kaisani A, Kumar R, et al. Targeting of Nrf2 induces DNA damage signaling and protects colonic epithelial cells from ionizing radiation. Proceedings of the National Academy of Sciences of the United States of America. 2012;109:E2949-55.





24

48. Tope AM, Rogers PF. Evaluation of protective effects of sulforaphane on DNA damage caused by exposure to low levels of pesticide mixture using comet assay. Journal of environmental science and health Part B, Pesticides, food contaminants, and agricultural wastes. 2009;44:657-62. 49. Talalay P, Fahey JW, Healy ZR, Wehage SL, Benedict AL, Min C, et al. Sulforaphane mobilizes cellular defenses that protect skin against damage by UV radiation. Proceedings of the National Academy of Sciences of the United States of America. 2007;104:17500-5. 50. Rodier F, Coppe JP, Patil CK, Hoeijmakers WA, Munoz DP, Raza SR, et al. Persistent DNA damage signalling triggers senescence-associated inflammatory cytokine secretion. Nature cell biology. 2009;11:973-9. 51. Latorre E, Matheus N, Layunta E, Alcalde AI, Mesonero JE. IL-10 counteracts proinflammatory mediator evoked oxidative stress in Caco-2 cells. Mediators of inflammation. 2014;2014:982639. 52. Hofseth LJ, Saito Si, Hussain SP, Espey MG, Miranda KM, Araki Y, et al. Nitric oxide-induced cellular stress and p53 activation in chronic inflammation. Proceedings of the National Academy of Sciences of the United States of America. 2003;100:143-8. 53. Brentnall Ta, Crispin Da, Rabinovitch PS, Haggitt RC, Rubin CE, Stevens aC, et al. Mutations in the p53 gene: an early marker of neoplastic progression in ulcerative colitis. Gastroenterology. 1994;107:369-78. 54. van den Berg FM, Tigges AJ, Schipper ME, den Hartog-Jager FC, Kroes WG, Walboomers JM. Expression of the nuclear oncogene p53 in colon tumours. J Pathol. 1989;157:193-9. 55. Rodrigues NR, Rowan A, Smith ME, Kerr IB, Bodmer WF, Gannon JV, et al. p53 mutations in colorectal cancer. Proc Natl Acad Sci U S A. 1990;87:7555-9. 56. Sedelnikova OA, Bonner WM. GammaH2AX in cancer cells: a potential biomarker for cancer diagnostics, prediction and recurrence. Cell cycle. 2006;5:2909-13. 57. Banath JP, Macphail SH, Olive PL. Radiation sensitivity, H2AX phosphorylation, and kinetics of repair of DNA strand breaks in irradiated cervical cancer cell lines. Cancer Res. 2004;64:7144-9. 58. Yu T, MacPhail SH, Banath JP, Klokov D, Olive PL. Endogenous expression of phosphorylated histone H2AX in tumors in relation to DNA double-strand breaks and genomic instability. DNA Repair (Amst). 2006;5:935-46.




Published OnlineFirst January 29, 2018.Mol Cancer Res Adrian Frick, Vineeta Khare, Gregor Paul, et al. and Human Colitis and Colitis-associated NeoplasiaOvert Increase of Oxidative Stress and DNA Damage in Murine

Updated version

10.1158/1541-7786.MCR-17-0451doi:

Access the most recent version of this article at:

Material

Supplementary

http://mcr.aacrjournals.org/content/suppl/2018/01/26/1541-7786.MCR-17-0451.DC1

Access the most recent supplemental material at:

Manuscript

Authorbeen edited. Author manuscripts have been peer reviewed and accepted for publication but have not yet

E-mail alerts related to this article or journal.Sign up to receive free email-alerts

Subscriptions

Reprints and

[email protected] at

To order reprints of this article or to subscribe to the journal, contact the AACR Publications

Permissions

Rightslink site. Click on "Request Permissions" which will take you to the Copyright Clearance Center's (CCC)

.http://mcr.aacrjournals.org/content/early/2018/01/26/1541-7786.MCR-17-0451To request permission to re-use all or part of this article, use this link



http://mcr.aacrjournals.org/lookup/doi/10.1158/1541-7786.MCR-17-0451

http://mcr.aacrjournals.org/content/suppl/2018/01/26/1541-7786.MCR-17-0451.DC1

http://mcr.aacrjournals.org/cgi/alerts

mailto:[email protected]

http://mcr.aacrjournals.org/content/early/2018/01/26/1541-7786.MCR-17-0451


overt increase of oxidative stress and dna damage in ......overt increase of oxidative stress and...

Documents